Skip to main content

Chad Cohen

Equibles does not estimate personal net worth.

Get an email with a short summary when Grindr Inc. publishes a filing, an earnings call transcript or a press release.

Get GRND alerts

About Chad Cohen

Chad Cohen is recorded as Board Member at Grindr Inc. (GRND). The newest filing on record that lists Chad Cohen as Board Member at Grindr Inc. (GRND) is dated April 30, 2026. Chad Cohen was last confirmed as CFO at Adaptive Biotechnologies Corp (ADPT) in a filing dated April 28, 2023. Earlier roles on record: CFO at Adaptive Biotechnologies Corp (ADPT) until February 15, 2022. Grindr Inc. reported in an 8-K filed June 3, 2025 that Chad Cohen was appointed member of the Board, effective June 3, 2025. The proxy statement of Adaptive Biotechnologies Corp reports total compensation of $72,221 for Chad Cohen in fiscal 2022, including a base salary of $54,063. Disclosed compensation is on record for 3 fiscal years. Chad Cohen has spoken on 7 earnings calls across 1 company, most recently for Adaptive Biotechnologies Corp on November 3, 2021. Grindr Inc. is classified in the Software - Application industry within the Technology sector. Other companies whose calls Chad Cohen spoke on are classified in the Healthcare sector. Other leadership on record at Grindr Inc. includes George Arison (CEO and Board Member), Jeffrey C. Bonforte (CEO), Gary C. Hsueh (CFO) and 7 others.

“On the Effective Date, the Board appointed Chad Cohen to serve as a member of the Board to fill the vacancy created by Mr. Horowitz's resignation.”
Grindr Inc. Form 8-K, filed June 3, 2025 · Read the filing

Chad Cohen on recent calls

“Turning to our financial results on Slide 7. Total revenue in the third quarter was $39.5 million, representing a 50% increase from $26.3 million in the same period last year.”
CFO, Adaptive Biotechnologies Corp Q3 FY2021 Earnings Call ·
“Turning to our financial results on Slide 8. Total revenue in the second quarter was $38.5 million, representing an 83% increase from $21 million in the same period last year.”
CFO, Adaptive Biotechnologies Corp Q2 FY2021 Earnings Call ·
“Turning to our financial results on Slide 10, total revenue in the first quarter was $38.4 million, representing an 84% increase from $20.9 million in the same period last year.”
CFO, Adaptive Biotechnologies Corp Q1 FY2021 Earnings Call ·
“I'll first review our fourth-quarter financial results, briefly describe our full-year financial performance, and then provide an outlook on 2021. Turning to Slide 11.”
CFO, Adaptive Biotechnologies Corp Q4 FY2020 Earnings Call ·
“Switching to our clinical diagnostic business with clonoSEQ on Slide 8, clonoSEQ Q3 sequencing volumes grew 58% versus prior year and 28% versus the prior quarter.”
CFO, Adaptive Biotechnologies Corp Q3 FY2020 Earnings Call ·

Affiliation history

Company network

Current role

Software - Application · Technology

Board Member

Leadership on record at Grindr Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Adaptive Biotechnologies Corp (ADPT) $54,063 $72,221
2021 Adaptive Biotechnologies Corp (ADPT) $429,375 $2,911,839
2020 Adaptive Biotechnologies Corp (ADPT) $411,950 $2,329,752

Recent activity